HomeCompareABC vs JNJ

ABC vs JNJ: Dividend Comparison 2026

ABC yields 1.08% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABC wins by $385.00 in total portfolio value
10 years
ABC
ABC
● Live price
1.08%
Share price
$179.98
Annual div
$1.94
5Y div CAGR
34.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.8K
Annual income
$2,940.21
Full ABC calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — ABC vs JNJ

📍 ABC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABC
Annual income on $10K today (after 15% tax)
$91.62/yr
After 10yr DRIP, annual income (after tax)
$2,499.18/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $1,538.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABC + JNJ for your $10,000?

ABC: 50%JNJ: 50%
100% JNJ50/50100% ABC
Portfolio after 10yr
$30.6K
Annual income
$3,845.04/yr
Blended yield
12.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABC right now

ABC
Analyst Ratings
20
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$171.00
-5.0% upside vs current
Range: $150.00 — $190.00
Altman Z
4.6
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABC buys
0
JNJ buys
0
No recent congressional trades found for ABC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABCJNJ
Forward yield1.08%2.14%
Annual dividend / share$1.94$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR34.4%28%
Portfolio after 10y$30.8K$30.5K
Annual income after 10y$2,940.21$4,749.88
Total dividends collected$9.6K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$171.00$228.73

Year-by-year: ABC vs JNJ ($10,000, DRIP)

YearABC PortfolioABC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,845$144.87$10,594$274.49+$251.00ABC
2$11,801$197.34$11,294$360.69+$507.00ABC
3$12,897$269.74$12,133$476.91+$764.00ABC
4$14,170$370.27$13,156$635.42+$1.0KABC
5$15,673$510.99$14,432$854.61+$1.2KABC
6$17,480$709.92$16,056$1,162.76+$1.4KABC
7$19,698$994.53$18,175$1,604.53+$1.5KABC
8$22,485$1,407.72$21,009$2,252.68+$1.5KABC
9$26,077$2,018.33$24,911$3,229.73+$1.2KABC
10$30,843$2,940.21$30,458$4,749.88+$385.00ABC

ABC vs JNJ: Complete Analysis 2026

ABCStock

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Full ABC Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ABC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABC vs SCHDABC vs JEPIABC vs OABC vs KOABC vs MAINABC vs ABBVABC vs MRKABC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.